Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation

European Neurology

Volumn 48, Issue 3, 2002, Pages 178-180

  Russmann, S ^a   Winkler, A ^a   Lovblad K O ^a   Stanga, Z ^a   Bassetti, Claudio ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLEOMYCIN; CANNABINOID; CANNABIS; CISPLATIN; ETOPOSIDE; HEPARIN; PHENYTOIN;

ADULT; ANAMNESIS; ARTICLE; BLOOD CLOTTING TEST; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; DRUG SCREENING; GERM CELL TUMOR; HUMAN; INHALATION; MALE; MIDDLE CEREBRAL ARTERY; ORCHIECTOMY; PARESIS; PARESTHESIA; PRIORITY JOURNAL; SMOKING; TESTIS CARCINOMA; TINNITUS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CANNABIS; CARBOPLATIN; CEREBROVASCULAR ACCIDENT; DRUG INTERACTIONS; ETOPOSIDE; FATAL OUTCOME; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 0036427069     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065511     Document Type: Article

References (15)

1. Graus F, Rogers LR, Posner JB: Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985;64:16-35.
2. Doll DC, Ringenberg QS, Yarbro JW: Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1986;4:1405-1417.
3. El Amrami M, Heinzlef O, Debroucker T, et al: Brain infarction following 5-fluorouracil and cisplatin therapy. Neurology 1998;51:899-901.
4. Gamble GE, Tyrell P: Acute stroke following cisplatin therapy. Clin Oncol (R Coll Radiol) 1998;10:274-275.
5. Gerl A: Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs 1994;5:607-614.
6. Goldhirsch A, Joss R, Markwalder TM, et al: Acute cerebrovascular accident after treatment with cis-platinum and methylprednisolone. Oncology 1983;40:344-345.
7. Içli F, Karaoguz H, Dinçol D, et al: Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 1993;72:587-593.
8. Kukla LJ, McGuire WP, Lad T, Saltiel M: Acute vascular episodes associated with therapy for carcinomas of the upper aerodigestive tract with bleomycin, vincristine, and cisplatin. Cancer Treat Rep 1982;66:369-370.
9. Serrano-Castro PJ, Guardado-Santervas P, Olivares-Romero J: Ischemic stroke following cisplatin and 5-fluorouracil: A transcranial Doppler study. Eur Neurol 2000;44:63-64.
10. Zacharian SB: Stroke after heavy marijuana smoking. Stroke 1991;22:406-409.
11. Gerl A: Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs 1994;5:607-614.
12. Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ: Raynaud's phenomenon: A common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med 1981;95:288-292.
13. Licciardello JTW, Moake JL, Rudy CK, et al: Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985;42:296-300.
14. Taher A, Shamsseddine A, Saghir N, et al: Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report. Eur J Gynaecol Oncol 1999;20:323-324.
15. Vincent BJ, McQuiston DJ, Einhorn LH, Nagy CM, Brames MJ: Review of cannabinoids and their antiemetic effectiveness. Drugs 1983;25(suppl 1): 52-62.